ATE491952T1 - Screening auf inhibitoren des eindringens von hepatitis-c-virus - Google Patents
Screening auf inhibitoren des eindringens von hepatitis-c-virusInfo
- Publication number
- ATE491952T1 ATE491952T1 AT02802643T AT02802643T ATE491952T1 AT E491952 T1 ATE491952 T1 AT E491952T1 AT 02802643 T AT02802643 T AT 02802643T AT 02802643 T AT02802643 T AT 02802643T AT E491952 T1 ATE491952 T1 AT E491952T1
- Authority
- AT
- Austria
- Prior art keywords
- screening
- methods
- hepatitis
- inhibitors
- cell
- Prior art date
Links
- 238000012216 screening Methods 0.000 title abstract 2
- 241000711549 Hepacivirus C Species 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000011835 investigation Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 108091005484 scavenger receptor class B Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34450401P | 2001-11-09 | 2001-11-09 | |
| PCT/EP2002/012272 WO2003040726A2 (en) | 2001-11-09 | 2002-11-01 | Screening for hepatitis c virus entry inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491952T1 true ATE491952T1 (de) | 2011-01-15 |
Family
ID=23350803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02802643T ATE491952T1 (de) | 2001-11-09 | 2002-11-01 | Screening auf inhibitoren des eindringens von hepatitis-c-virus |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20050019751A1 (https=) |
| EP (1) | EP1444523B1 (https=) |
| JP (1) | JP2005509160A (https=) |
| AT (1) | ATE491952T1 (https=) |
| CA (1) | CA2465731A1 (https=) |
| DE (1) | DE60238633D1 (https=) |
| WO (1) | WO2003040726A2 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0315248D0 (en) * | 2003-06-30 | 2003-08-06 | Hoffmann La Roche | HCV regulated protein expression |
| AU2005262006B2 (en) * | 2004-07-08 | 2011-01-27 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication |
| WO2006103493A1 (en) * | 2005-03-29 | 2006-10-05 | Epixis | Methods for enhancing the potency of hcv neutralizing antibodies |
| EP1832283A1 (en) * | 2006-03-09 | 2007-09-12 | Cenix Bioscience GmbH | Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases |
| US20090324580A1 (en) | 2006-03-09 | 2009-12-31 | Cenix Bioscience Gmbh | Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases |
| WO2008013918A2 (en) * | 2006-07-26 | 2008-01-31 | Myelin Repair Foundation, Inc. | Cell cycle regulation and differentiation |
| US9052321B2 (en) * | 2008-10-03 | 2015-06-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Flavivirus-based system for production of hepatitis C virus (HCV) |
| WO2017081595A1 (en) * | 2015-11-12 | 2017-05-18 | Sabic Global Technologies B.V. | Methods for producing aromatics and olefins |
| CN112121168B (zh) * | 2020-04-09 | 2022-03-04 | 中国人民解放军军事科学院军事医学研究院 | 一种抑制剂在制备治疗SARS-CoV-2肺炎及其并发症的药物中的应用 |
| JP2025531751A (ja) * | 2022-09-07 | 2025-09-25 | ユナイテッド キングダム リサーチ アンド イノベーション | 代謝関連疾患のための治療薬 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
| US5925333A (en) * | 1995-11-15 | 1999-07-20 | Massachusetts Institute Of Technology | Methods for modulation of lipid uptake |
| US5998141A (en) * | 1997-07-10 | 1999-12-07 | Millennium Pharmaceuticals, Inc. | Intronic and polymorphic SR-BI nucleic acids and uses therefor |
-
2002
- 2002-11-01 AT AT02802643T patent/ATE491952T1/de not_active IP Right Cessation
- 2002-11-01 JP JP2003542928A patent/JP2005509160A/ja not_active Withdrawn
- 2002-11-01 DE DE60238633T patent/DE60238633D1/de not_active Expired - Lifetime
- 2002-11-01 US US10/494,555 patent/US20050019751A1/en not_active Abandoned
- 2002-11-01 WO PCT/EP2002/012272 patent/WO2003040726A2/en not_active Ceased
- 2002-11-01 CA CA002465731A patent/CA2465731A1/en not_active Abandoned
- 2002-11-01 EP EP02802643A patent/EP1444523B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20050019751A1 (en) | 2005-01-27 |
| CA2465731A1 (en) | 2003-05-15 |
| JP2005509160A (ja) | 2005-04-07 |
| EP1444523A2 (en) | 2004-08-11 |
| WO2003040726A3 (en) | 2003-12-18 |
| WO2003040726A2 (en) | 2003-05-15 |
| DE60238633D1 (de) | 2011-01-27 |
| EP1444523B1 (en) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0113161A (pt) | Arilóxi piperidinas não imidazóis | |
| ATE217865T1 (de) | Verbindungen zur hemmung von phosphodiesrerase iv | |
| CY1113038T1 (el) | Τριετεροκυκλικες ενωσεις, συνθεσεις, και μεθοδοι για τη θεραπεια καρκινου | |
| EA200700243A1 (ru) | Способы лечения гепатита с | |
| BRPI0515596A (pt) | composição farmacêutica usada para o tratamento e/ou prevenção de hcv, e, métodos de inibir rna polimerase ns5b de hepatite c de tratar ou prevenir infecção por hepatite c em um mamìfero | |
| EA200601552A1 (ru) | Замещенные конденсированные гетероциклические с-гликозиды | |
| DE60336550D1 (de) | Inhibitoren des hepatitis-c-virus | |
| PT1742642E (pt) | Análogos de fosfonato de compostos inibidores da integrase do hiv | |
| WO2007084413A3 (en) | Methods for treating hepatitis c | |
| IS7532A (is) | Heterósýklískir súlfónamíð lifrarbólgu C-veirutálmar | |
| CY1108655T1 (el) | ΘΕΙΟΖΟΛΙΔΙΝ-4-ΟΝΕΣ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΠΡΩΤΕΪΝΩΝ hYAK3 | |
| ATE491952T1 (de) | Screening auf inhibitoren des eindringens von hepatitis-c-virus | |
| ATE552347T1 (de) | Oligonukleotidverbindung und verfahren zur behandlung von nidovirusinfektionen | |
| DE60039783D1 (de) | Lfa-1 antagonisten und tnf-alpha antagonisten zur | |
| DE60039729D1 (de) | N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen | |
| BR0211200A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| ATE361922T1 (de) | Pyrrol-substituierte indole als inhibitoren von pai-1 | |
| ATE316531T1 (de) | Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1 | |
| DK1480627T3 (da) | Fremgangsmåder til mindskelse af angiogenese | |
| DE602004004883D1 (de) | Vegf-antagonisten zur behandlung von diabetes | |
| ATE498398T1 (de) | Cycloalkyl-heterozyklen zur behandlung des hepatitis-c-virus | |
| WO2009069132A3 (en) | Novel reverse transcriptase inhibitors | |
| DK1511472T3 (da) | Anvendelige forbindelser til behandling af Anthrax og hæmning af letalfaktor | |
| BR0311223A (pt) | Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c | |
| BRPI0409405A (pt) | compostos 7-aza-quinazolina substituìdos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |